Parkinson's Disease Blood Test
Reliable, accurate and minimally-invasive detection of Parkinson’s Disease
Transforming Parkinson’s Diagnosis
A revolutionary blood test built from cutting-edge research
Our mission is to bring lab breakthroughs to the clinic, starting with a blood-based diagnostic for Parkinson’s disease.
Who We Are
Revolutionizing Amyloid Disease Management
Amyscan envisions transforming the diagnosis and management of amyloid-based diseases by translating cutting-edge research into high-throughput and clinically accessible diagnostic tools. We aim to develop early and accurate amyloid detection technologies and build a new standard in patient care—one that facilitates timely intervention and paves the way for more effective treatment strategies.
Parkinson’s?
Understand Parkinson's Disease and How it is Diagnosed
Today, diagnosis relies largely on the clinical observation of motor and non-motor symptoms, identifying Parkinson’s-specific signs while ruling out other conditions with overlapping features. This complexity means that diagnosing Parkinson’s is often a slow and gradual process.
What We Offer - More than a Blood Test
Minimally
Invasive
Highly
Accurate
Clinically
Validated
